H2AX and hepatocellular carcinoma: Here, we found that the H2AFX over‐expression levels were correlated with the low overall survival and disease‐specific survival of patients with liver cancer, suggesting that over‐expression of H2AFX mRNA will reduce the HCC patients survival with liver cancer and may reduce the resistance of patients to other diseases.